相关实验视频
Updated: Jun 29, 2025

05:42
The Forced Swim Test as a Model of Depressive-like Behavior
Published on: March 2, 2015
37.3K
在SLE患者中抑郁和焦虑的一年结果
Liliana Duca1,2, Nadinne Alexandra Roman1,3, Petru Ifteni1,3
1Faculty of Medicine, Transilvania University of Braşov, 500036 Braşov, Romania.
Biomedicines
|March 28, 2024
概括
神经精神病系统性红斑狼 (NPSLE) 管理表明精神病治疗的有效性有限. 特定于SLE的药物,如甲和Plaquenil,可以减少患者的焦虑和抑郁症状.
科学领域:
- 免疫学 免疫学 免疫学
- 神经学 神经学
- 精神病学是一个精神病学.
背景情况:
- 神经精神系统性红斑狼 (NPSLE) 是SLE的严重表现,影响神经和精神功能.
- 患有SLE的患者经常经历认知障碍,抑郁和焦虑,但缺乏专门的精神病治疗指南.
- 这项研究解决了了解NPSLE症状进展和识别潜在生物标志物的需要.
研究的目的:
- 纵向调查SLE患者一年内焦虑和抑郁症的进展情况.
- 为了确定与NPSLE相关的潜在生物标志物.
- 探索NPSLE和SLE疾病总体活动之间的关系.
主要方法:
- 一项涉及65名成年SLE患者的纵向研究.
- 使用了物理,生化和血清学测试,以及疾病活动指数 (BILAG-2004,SLEDAI-2K).
- 使用汉密尔顿焦虑和抑郁评分尺度进行员工心理评估.
主要成果:
- 抗抑郁药物治疗对焦虑和抑郁症没有显著影响.
- 甲索和普拉奎尼尔显著降低了焦虑和抑郁症状.
- 抗焦虑药物治疗似乎影响了抑郁症,而焦虑水平随着时间的推移而增加,独立于SLE活动.
结论:
- 特定的SLE药物可以调节焦虑和抑郁水平,但神经精神病治疗的整体有效性有限.
- 需要进一步的研究来定制NPSLE管理,并更深入地了解其精神方面的维度.
- 随着时间的推移,SLE患者的焦虑水平可能会增加,与疾病活动没有直接相关.
相关概念视频
Stress and Mental Health
155
Chronic stress profoundly affects mental health, significantly influencing mood, behavior, and overall quality of life. Research closely links chronic stress with mental health conditions such as depression, anxiety, and substance use disorders. Ongoing exposure to stress can lead to physiological and psychological changes, initiating a cycle of emotional distress and maladaptive coping mechanisms.
Individuals with depression often experience challenges in both their personal and professional...
Individuals with depression often experience challenges in both their personal and professional...
155
Depressive Disorders: MDD and Dysthymia
117
Depressive disorders are a group of mental health conditions characterized by pervasive feelings of sadness, diminished pleasure in life, and a significant impact on daily functioning. These conditions are most prevalent in individuals during their 30s and affect women at twice the rate of men. Contrary to popular belief, younger individuals are generally more susceptible to these disorders than older adults. Two key types of depressive disorders include Major Depressive Disorder (MDD) and...
117
Anxiety: Overview
267
Anxiety is a common mental disorder featuring excessive worry, fear, and apprehension, significantly affecting daily life. People with anxiety disorders experience persistent and intense anxiety, interrupting their everyday functioning.
Individuals with anxiety often experience a range of physical and emotional symptoms, including sweating, trembling, tachycardia, and disturbances in sleep patterns. These symptoms vary in intensity and frequency but are generally disruptive and distressing.
Individuals with anxiety often experience a range of physical and emotional symptoms, including sweating, trembling, tachycardia, and disturbances in sleep patterns. These symptoms vary in intensity and frequency but are generally disruptive and distressing.
267
Depression: Overview
242
Depression is a prevalent mental illness marked by persistent sadness and lack of interest in previously enjoyable activities. It can take several forms, including major depression, persistent depressive disorder, and bipolar I and II disorders. Symptoms range from emotional changes like chronic worry to physical changes like sleep disturbances and suicidal thoughts. From a neurobiological perspective, depression is believed to be triggered by abnormalities in the brain's prefrontal cortex,...
242
Anxiolytic Drugs: Overview
293
Anxiolytic drugs are vital in managing anxiety disorders by effectively alleviating symptoms such as excessive fear, tachycardia, and tremors. There are several classes of anxiolytic medications, each with unique mechanisms of action and potential side effects.
Primary Types of Anxiolytic Drugs
1. Benzodiazepines:
Benzodiazepines bind to the GABA-A receptor in the brain, enhancing GABA's interaction. This action reduces neurotransmission, effectively blocking anxiety-associated limbic...
Primary Types of Anxiolytic Drugs
1. Benzodiazepines:
Benzodiazepines bind to the GABA-A receptor in the brain, enhancing GABA's interaction. This action reduces neurotransmission, effectively blocking anxiety-associated limbic...
293

